首页> 中文期刊> 《中国实用医刊》 >TIMI评分对急性心肌梗死患者危险分层及预后评估的临床价值

TIMI评分对急性心肌梗死患者危险分层及预后评估的临床价值

摘要

目的 探讨心肌梗死溶栓疗法(TIMI)危险评分系统对急性心肌梗死(acute myocardialinfarction,AMI)患者危险分层及预后评估的临床价值.方法 应用TIMI危险评分对133例AMI患者入院时进行评分,根据其分值分为低分组、中分组和高分组.观察患者12个月的主要心血管事件(包括非致命性再次心肌梗死、非致命性心力衰竭、反复心绞痛发作与心脏性死亡)发生率.结果 133例AMI患者12个月共发生心血管事件27例(发生率20.3%),随危险评分值的逐渐递增,其心血管事件发生率进行性增高.结论 入院时AMI患者TIMI危险评分值高,临床预后较差;TIMI危险评分系统对AMI患者危险分层方便实用,评估预后具有一定的临床价值.%Objective To investigate the treatment of thrombolysis in myocardial infarction (TIMI) risk scoring system for acute myocardial infarction (AMI) patients risk stratification and prognosis of clinical value. Methods The TIMI risk score was used for 133 AMI patients admitted to hospital, and the patients were divided into low, medium group and high group according to their scores. The major cardiovascular events ( including non - fatal myocardial re - infarction, non - fatal heart failure, recurrent angina and cardiac death) rate of the patients in 12 months were observed. Results The 12 - month cardiac events occurred in 27 cases ( incidence 20.3 %) , with the value of the incremental risk score, their rates of cardiovascular events increased. Conclusions Patients with high TIMI risk score value have poorer clinical prognosis, TIMI risk score is convenient and practical in risk stratification of patients with AMI, and has some clinical value in assessing the prognosis of the disease.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号